Dire Wolves! They're Back?

Episode Summary

Executive Summary: The episode examines Colossal’s claim to have “brought back” dire wolves by editing gray wolf DNA, arguing these animals are closer to engineered proxies than true de-extinct dire wolves. It weighs the scientific novelty and biotech potential against ethical concerns, animal welfare risks, weak regulation, and the possibility that spectacle and fundraising matter more than conservation.

Main Topics: Are these really dire wolves? (Priority: 5/5): The central question is whether Colossal’s wolves qualify as dire wolves or are genetically edited gray wolves with a few dire-wolf traits. The discussion stresses that the animals are impressive, but classification is scientifically and philosophically contested. How Colossal made the animals (Priority: 5/5): Colossal used ancient DNA from dire wolf remains, identified the gray wolf as the closest living relative, and edited a limited number of genes in gray wolves before creating the pups through reproductive tech. Startup culture, funding, and hype (Priority: 4/5): The company is portrayed as a highly successful startup with major investors and celebrity attention, raising questions about whether publicity and biotech spin-offs are as important as the animals themselves. Technical limits and scientific uncertainty (Priority: 5/5): Experts explain that editing a handful of genes cannot recreate a lost species in full, and gene editing can have unintended effects because genes have multiple functions that are not fully understood. Animal welfare and ethical concerns (Priority: 5/5): A bioethics expert argues the process requires invasive procedures in dogs or elephants, potentially harms animals, and raises doubts about whether the project serves animals or commercial goals. Regulation and conservation priorities (Priority: 4/5): The transcript highlights the lack of government regulation for de-extinction and contrasts spending on speculative projects with underfunded conservation and NIH research that could yield broader public benefit.

Key Arguments: Colossal’s wolves are not true dire wolves in a strict biological sense; they are gray wolves edited at a limited number of genes to resemble dire wolves. De-extinction is much harder than it sounds: ancient DNA can be recovered, but recreating a species requires many technical steps with major failure points. The project may be scientifically interesting, but the biggest benefits could be proprietary biotech tools rather than species restoration. The company’s business model and fundraising success show serious market confidence, but also suggest publicity is part of the strategy. Gene editing has unpredictable side effects because genes influence multiple traits; changing one trait can unintentionally cause disease or disability. The animal welfare costs of creating large mammals this way could be substantial, especially if the long-term mammoth goal involves many elephant pregnancies and C-sections. There are currently no meaningful government regulations governing de-extinction, leaving ethics and oversight largely to the companies themselves. Conservation dollars may be better spent protecting species and habitats that still exist than trying to recreate extinct animals. The public promise of ecological restoration may be overstated; for some species, like the dire wolf, only a few individuals are planned, making ecological impact minimal. Public research institutions and NIH-funded science may offer broader, more transparent benefits than a privately held company that does not publish much of its work.

Data Points: genes edited in initial dire wolf claim: 14 genes - Science Versus intro describing Colossal’s promotional framing genes edited in later explanation: 20 edits - DT Max describing the gray wolf genome edits used to make the animals ancient DNA source age: 72,000-year-old bone - Dire wolf inner ear bone used for DNA extraction ancient DNA source age: 13,000-year-old tooth - Second dire wolf DNA source time since extinction: about 14,000 years ago - When dire wolves disappeared from the Americas company funding raised: over $400 million - Colossal’s total capital raised company valuation: over $10 billion - Approximate market valuation of Colossal number of wolves created: 3 - Bioethics discussion noting Colossal has created three animals planned lifespan: about 15 years - Expected lifespan for the wolves, similar to a smaller dog enclosure size: about 3 square miles - Space Colossal keeps the wolves in typical wild range: 50 to 1,000 square miles - Normal territory range for wolves potential dire-wolf genes not edited: 5 genes - Researchers avoided these because they could cause deafness or blindness human genome-editing case mentioned: 3 children - Reference to He Jiankui’s CRISPR experiment in China

Pivotal Quotes: "We either have to put dire wolves in quotes, or we have to give them a name." — DT Max: Summing up the debate over whether Colossal’s animals are truly dire wolves "These are not dire wolves by any definition." — DT Max: Critiquing the scientific and taxonomic accuracy of the company’s claim "The dire wolf is not ... there's a difference between being extinct for 40 million years and being extinct for 14,000 years." — DT Max: Explaining why ancient DNA recovery is possible here, but full de-extinction is still limited

Implications: Listeners are left with a cautionary view of de-extinction: it may accelerate biotech, but it also risks animal harm, hype-driven science, and distraction from conserving living species and habitats.